Measles-containing-vaccine first-dose (MCV1) immunization coverage in Timor-Leste
Timor-Leste: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 61.0% in 2025. ▲ Rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Timor-Leste, 2002–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine first-dose (mcv1) immunization coverage in Timor-Leste is 61.0%, measured in 2025.
That represents a change of down 15.3% on the previous year and down 12.9% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Timor-Leste peaked at 77.0% in 2017 and was at its lowest, 48.0%, in 2005.
Timor-Leste ranks 179th of 194 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Timor-Leste, year by year
| Year | Value | Change |
|---|---|---|
| 2002 | 56.0% | — |
| 2003 | 55.0% | -1.8% |
| 2004 | 55.0% | +0.0% |
| 2005 | 48.0% | -12.7% |
| 2006 | 61.0% | +27.1% |
| 2007 | 63.0% | +3.3% |
| 2008 | 73.0% | +15.9% |
| 2009 | 70.0% | -4.1% |
| 2010 | 66.0% | -5.7% |
| 2011 | 62.0% | -6.1% |
| 2012 | 73.0% | +17.7% |
| 2013 | 70.0% | -4.1% |
| 2014 | 74.0% | +5.7% |
| 2015 | 70.0% | -5.4% |
| 2016 | 73.0% | +4.3% |
| 2017 | 77.0% | +5.5% |
| 2018 | 77.0% | +0.0% |
| 2019 | 75.0% | -2.6% |
| 2020 | 74.0% | -1.3% |
| 2021 | 72.0% | -2.7% |
| 2022 | 72.0% | +0.0% |
| 2023 | 72.0% | +0.0% |
| 2024 | 72.0% | +0.0% |
| 2025 | 61.0% | -15.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.1% | 48.0% | 73.0% | 8 |
| 2010s | 71.7% | 62.0% | 77.0% | 10 |
| 2020s | 70.5% | 61.0% | 74.0% | 6 |
Countries ranked near Timor-Leste
- 176 Guinea 62.0% compare
- 176 Equatorial Guinea 62.0% compare
- 176 Haiti 62.0% compare
- 179 Somalia 61.0% compare
- 181 Côte d'Ivoire 58.0% compare
- 181 Lao People's Democratic Republic 58.0% compare
More health data for Timor-Leste
- Heat deaths vs projected death rates, annual growth rate 0.894 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -1.22 % change on previous year (2100)
- Heat deaths vs projected death rates 1,287 (2090)
- Un projection of annual infant deaths 162 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 09, female, interpolated 16,348 (2025)
- Age population, age 12, male, interpolated 15,603 (2025)
- Age population, age 12, female, interpolated 15,049 (2025)
- Age population, age 11, female, interpolated 15,503 (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Timor-Leste?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Timor-Leste was 61.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Timor-Leste?
- The highest recorded value was 77.0% in 2017.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Timor-Leste?
- The lowest recorded value was 48.0% in 2005.
- How does Timor-Leste rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Timor-Leste ranks 179th out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Timor-Leste?
- Over the last ten years it is down 12.9%. The long-run trend across the full record is rising.
- Where does this Timor-Leste data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).